|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||42.85 - 42.85|
|52 Week Range||42.85 - 51.88|
|Beta (5Y Monthly)||1.48|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Moody's Investors Service, ("Moody's") has today confirmed all ratings of Imerys S.A. (Imerys) including the company's Baa2 senior unsecured ratings as well as the issuer's P-2 Commercial Paper rating. The outlook has been changed to negative from rating under review. Moody's believes that Imerys' performance will improve from currently depressed levels during the course of 2020, mainly driven by the lack of one-off expenses, and assuming that, despite cyclical pressure in some of its end markets such as manufacturing, automotive, paper the results overall will be relatively stable.
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Imerys S.A. Frankfurt am Main, November 01, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Imerys S.A. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
Moody's Investors Service ("Moody's") has today placed all ratings of Imerys S.A. ("Imerys" or "the issuer") on review for downgrade including the company's Baa2 senior unsecured ratings as well as the issuer's P-2 Commercial Paper rating. The outlook has been changed to rating under review from stable. The review for downgrade was prompted by Imerys' ad hoc announcement on 22nd October 2019.
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the...
J&J shares fell more than 6% to close at $127.70. The move marks the first time the company has recalled its iconic baby powder for possible asbestos contamination, and the first time U.S. regulators have announced a finding of asbestos in the product. Asbestos is a known carcinogen that has been linked to deadly mesothelioma.
If you want to know who really controls Imerys S.A. (EPA:NK), then you'll have to look at the makeup of its share...
PARIS (Reuters) - Shares in French telecoms group Iliad fell on Tuesday, as concerns over its weak results overshadowed possible plans to sell part of Iliad's mobile assets. Iliad shares were down 3.7 ...